News Formal

Kellogg's cereal business begins trading as standalone company W.K. Kellogg

  • 📰 NBCLA
  • ⏱ Reading Time:
  • 50 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 59%

Italia Notizia Notizia

Italia Ultime Notizie,Italia Notizie

As part of the separation, Kellogg has been renamed Kellanova but is still trading under the ticker “K.”

W.K. Kellogg, a spinoff of Kellogg's cereal business, began trading on the New York Stock Exchange.

As part of the separation, Kellogg has been renamed Kellanova but is still trading under the ticker"K." Shareholders received one share of W.K. Kellogg for every four shares of Kellogg they owned as of Sept. 21. Kellogg's cereal business began trading on the New York Stock Exchange at $13.80 per share as W.K. Kellogg after spinning off from its parent company on Monday morning.. It now houses snacking brands like Pringles and Cheez-It and its North American frozen-food unit, which includes Morningstar Farms.Get Southern California news, weather forecasts and entertainment stories to your inbox.Shares of Kellanova were down roughly 3% in morning trading, and W.K. Kellogg's stock fell 5%.

Shareholders received one share of W.K. Kellogg for every four shares of Kellogg they owned as of Sept. 21.the planned separation in June 2022. Cereal sales have stagnated as consumers choose from a wider variety of options for breakfast and prioritize convenience.

 

Grazie per il tuo commento. Il tuo commento verrà pubblicato dopo essere stato esaminato.
Abbiamo riassunto questa notizia in modo che tu possa leggerla velocemente. Se sei interessato alla notizia puoi leggere il testo completo qui. Leggi di più:

 /  🏆 319. in İT

Italia Ultime Notizie, Italia Notizie

Similar News:Puoi anche leggere notizie simili a questa che abbiamo raccolto da altre fonti di notizie.

Big Food vs. Big Pharma: Companies bet on snacking just as weight loss drugs boomKellogg, J.M. Smucker and other food companies are making big bets on snacking, but the rise of Wegovy and Ozempic could pose a threat to future sales growth.
Fonte: NBCLA - 🏆 319. / 59 Leggi di più »